- Home
- OTLK vs GAME Comparison
OTLK vs GAME Comparison
Compare OTLK & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OTLK | GAME |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 43.4M |
| IPO Year | 2016 | 2024 |
Fundamental Metrics
Financial Performance| Metric | OTLK | GAME |
|---|---|---|
| Price | $0.78 | $0.40 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 23.7M | 1.6M |
| Earning Date | 05-14-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 55.91 | ★ 65.14 |
| EPS | N/A | ★ N/A |
| Revenue | $8,146,123.00 | ★ $44,999,302.00 |
| Revenue This Year | $1,430.98 | $87.12 |
| Revenue Next Year | $173.23 | $21.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $0.24 |
| 52 Week High | $3.39 | $2.87 |
Technical Indicators
Market Signals| Indicator | OTLK | GAME |
|---|---|---|
| Relative Strength Index (RSI) | 74.55 | 46.05 |
| Support Level | $0.42 | $0.39 |
| Resistance Level | $1.18 | $0.49 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 74.57 | 31.44 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.